BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32056305)

  • 1. Kinesin family member 2C aggravates the progression of hepatocellular carcinoma and interacts with competing endogenous RNA.
    Zhang GP; Shen SL; Yu Y; Yue X; Hu WJ; Li SQ
    J Cell Biochem; 2020 Nov; 121(11):4419-4430. PubMed ID: 32056305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNAs HERH-1 and HERH-4 facilitate cyclin A2 expression and accelerate cell cycle progression in advanced hepatocellular carcinoma.
    Liu T; Shi Q; Yang L; Wang S; Song H; Wang Z; Xu X; Liu H; Zheng H; Shen Z
    BMC Cancer; 2021 Aug; 21(1):957. PubMed ID: 34445994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinesin superfamily protein expression and its association with progression and prognosis in hepatocellular carcinoma.
    Chen J; Li S; Zhou S; Cao S; Lou Y; Shen H; Yin J; Li G
    J Cancer Res Ther; 2017; 13(4):651-659. PubMed ID: 28901309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
    Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
    J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA A1BG-AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR-216a-5p.
    Bai J; Yao B; Wang L; Sun L; Chen T; Liu R; Yin G; Xu Q; Yang W
    J Cell Biochem; 2019 Jun; 120(6):10310-10322. PubMed ID: 30556161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long intergenic noncoding RNA SNHG16 interacts with miR-195 to promote proliferation, invasion and tumorigenesis in hepatocellular carcinoma.
    Xie X; Xu X; Sun C; Yu Z
    Exp Cell Res; 2019 Oct; 383(1):111501. PubMed ID: 31306653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non‑coding RNA ZSCAN16‑AS1 promotes the malignant properties of hepatocellular carcinoma by decoying microRNA‑451a and consequently increasing ATF2 expression.
    Lv C; Wan Q; Shen C; Wu H; Zhou B; Wang W
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34498716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIF2C: a novel link between Wnt/β-catenin and mTORC1 signaling in the pathogenesis of hepatocellular carcinoma.
    Wei S; Dai M; Zhang C; Teng K; Wang F; Li H; Sun W; Feng Z; Kang T; Guan X; Xu R; Cai M; Xie D
    Protein Cell; 2021 Oct; 12(10):788-809. PubMed ID: 32748349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA PICSAR/miR-588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway.
    Liu Z; Mo H; Sun L; Wang L; Chen T; Yao B; Liu R; Niu Y; Tu K; Xu Q; Yang N
    Cancer Sci; 2020 Nov; 111(11):4118-4128. PubMed ID: 32860321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
    Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
    J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of competing endogenous RNA network identifies a poorly differentiated cancer-specific RNA signature for hepatocellular carcinoma.
    Chen QF; Huang T; Si-Tu QJ; Wu P; Shen L; Li W; Huang Z
    J Cell Biochem; 2020 Mar; 121(3):2303-2317. PubMed ID: 31642123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNGH16 regulates cell autophagy to promote Sorafenib Resistance through suppressing miR-23b-3p via sponging EGR1 in hepatocellular carcinoma.
    Jing Z; Ye X; Ma X; Hu X; Yang W; Shi J; Chen G; Gong L
    Cancer Med; 2020 Jun; 9(12):4324-4338. PubMed ID: 32324343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non‑coding RNA Fer‑1‑like family member 4 suppresses hepatocellular carcinoma cell proliferation by regulating PTEN in vitro and in vivo.
    Sun X; Zheng G; Li C; Liu C
    Mol Med Rep; 2019 Jan; 19(1):685-692. PubMed ID: 30431133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA DUXAP8 contributes to the progression of hepatocellular carcinoma via regulating miR-422a/PDK2 axis.
    Wei F; Yang L; Jiang D; Pan M; Tang G; Huang M; Zhang J
    Cancer Med; 2020 Apr; 9(7):2480-2490. PubMed ID: 32022476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC.
    Li Z; Wu G; Li J; Wang Y; Ju X; Jiang W
    BMC Cancer; 2020 Apr; 20(1):282. PubMed ID: 32252678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA GHET1 predicts poor prognosis in hepatocellular carcinoma and promotes cell proliferation by silencing KLF2.
    Jin L; He Y; Tang S; Huang S
    J Cell Physiol; 2018 Jun; 233(6):4726-4734. PubMed ID: 29139562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lncRNA DRHC inhibits proliferation and invasion in hepatocellular carcinoma via c-Myb-regulated MEK/ERK signaling.
    Zhuang R; Zhang X; Lu D; Wang J; Zhuo J; Wei X; Ling Q; Xie H; Zheng S; Xu X
    Mol Carcinog; 2019 Mar; 58(3):366-375. PubMed ID: 30362626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.